In individuals with type 2 diabetes, another phase 2 clinical study demonstrated that after 12 weeks of efinopegdutide treatment, although no significant improvement in glycated hemoglobin (HbA1c) levels was observed, the effect on weight loss reached a high of 7.9%, well above the 0.7% weight reduction rate in the placebo group
Canadian approval of semaglutide copy could lower GLP1 costs for plan sponsors Canada could see one of the first generic versions of Ozempic on the market as early as this year, potentially reshaping access to GLP1 drugs
The sooner you start these conversations, the better prepared your clients will be as renewals hit
0.1% (placebo) Steady State: Achieved after 4-5 weeks of weekly dosing Safety: Nausea (68% at 4.5 mg), vomiting (32%), generally mild-moderate and transient Discontinuation: 14% discontinued due to GI adverse events Appetite Effects: Significant reductions in Visual Analogue Scale (VAS) hunger scores Publication: Lau DCW, et al
A meta-analysis in 2020 of 587 women in 9 studies examined the use of probiotics or synbiotics (a combined supplement of prebiotics and probiotics) in women with PCOS